Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Total Non-Current Liabilities (2020 - 2025)

Precision Biosciences (DTIL) has disclosed Total Non-Current Liabilities for 6 consecutive years, with $52.2 million as the latest value for Q4 2025.

  • Quarterly Total Non-Current Liabilities fell 25.47% to $52.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.2 million through Dec 2025, down 25.47% year-over-year, with the annual reading at $52.2 million for FY2025, 25.47% down from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $52.2 million at Precision Biosciences, down from $72.8 million in the prior quarter.
  • The five-year high for Total Non-Current Liabilities was $203.1 million in Q1 2021, with the low at $52.2 million in Q4 2025.
  • Average Total Non-Current Liabilities over 5 years is $118.2 million, with a median of $117.7 million recorded in 2021.
  • The sharpest move saw Total Non-Current Liabilities surged 60.91% in 2022, then tumbled 48.15% in 2025.
  • Over 5 years, Total Non-Current Liabilities stood at $110.3 million in 2021, then skyrocketed by 60.91% to $177.5 million in 2022, then dropped by 26.26% to $130.9 million in 2023, then crashed by 46.54% to $70.0 million in 2024, then fell by 25.47% to $52.2 million in 2025.
  • According to Business Quant data, Total Non-Current Liabilities over the past three periods came in at $52.2 million, $72.8 million, and $72.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.